Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand
24 août 2023 08h05 HE
|
Trxade Health, Inc.
TAMPA, FL, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Superlatus Inc. ('Superlatus' or the 'Company') recently merged with TRxADE HEALTH, Inc. (NASDAQ: MEDS) and is gearing up to revolutionize the snack...
Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.
22 août 2023 08h05 HE
|
Trxade Health, Inc.
Combined company, focused on sustainable, equitable food portfolio, expected to more readily penetrate new markets and accelerate transition to animal-free brands Once complete, transaction...
TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
14 août 2023 10h25 HE
|
Trxade Health, Inc.
TAMPA, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced that it has filed for an extension to file...
Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team
03 août 2023 09h05 HE
|
Trxade Health, Inc.
Forbes Fisher Appointed as Chief Operating Officer.Dr. Eugenio Bortone Appointed as Chief Innovation & Food Technology Officer. TAMPA, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH,...
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.
31 juil. 2023 08h35 HE
|
Trxade Health, Inc.
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced the closing of the previously announced...
TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.
14 juil. 2023 16h30 HE
|
Trxade Health, Inc.
NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated...
TRxADE Health, Inc.’s Board of Directors Approves Reverse Stock Split
21 juin 2023 12h36 HE
|
Trxade Health, Inc.
Lutz, Florida, June 21, 2023 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (Nasdaq: MEDS) (the “Company”), today announced that its board of directors has approved a 1-for-15 reverse stock split of its...
TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results
15 mai 2023 16h15 HE
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, May 15, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the “Company”), a...
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results
07 nov. 2022 16h30 HE
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, Nov. 07, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the...
Bonum Health™, LLC (a TRxADE HEALTH Company) Strikes Strategic Business-to-Business (B2B) Telemedicine Services Agreement with Insurance Brokerage Firm(s) for Small-to-Medium Business (SMB) Employer Groups
25 oct. 2022 08h30 HE
|
Trxade Health, Inc.
TAMPA, FL, Oct. 25, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)(“TRxADE” or the “Company”) an integrated drug procurement, delivery, and healthcare platform, today announced that...